Adaptimmune Therapeutics News

Adaptimmune Therapeutics | 8-K: Current report

Apr 12 20:07

Adaptimmune Therapeutics | DEF 14A: Definitive information statements

Apr 11 20:04

Adaptimmune Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-New Enterprise Associates 14, L.P.(6.7%),NEA Partners 14, L.P.(6.7%), etc.

Apr 3 08:41

Adaptimmune Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 1 20:06

Adaptimmune Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner EcoR1 Capital, LLC

Mar 27 00:04

Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(10.7%),Oleg Nodelman(10.7%), etc.

Mar 27 00:04

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Piccina Cintia

Mar 19 05:01

Adaptimmune Therapeutics | 10-K: Annual report

Mar 6 20:18

Adaptimmune Therapeutics | 8-K: Current report

Mar 6 20:08

Adaptimmune Therapeutics | 8-K: Current report

Feb 27 21:16

Adaptimmune Therapeutics | 8-K: Current report

Feb 17 05:10

Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(4.8%),Baker Bros. Advisors (GP) LLC(4.8%), etc.

Feb 15 06:49

Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-LONG FOCUS CAPITAL MANAGEMENT, LLC(5.3%),JOHN B. HELMERS(5.3%), etc.

Feb 15 06:11

Adaptimmune Therapeutics | 8-K: Current report

Feb 1 06:13

Adaptimmune Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-EcoR1 Capital, LLC(7.7%),Oleg Nodelman(7.7%), etc.

Jan 31 06:29

Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baillie Gifford & Co (Scottish partnership)(7.01%)

Jan 30 00:53

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rawcliffe Adrian

Jan 17 13:00

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bertrand William C JR

Jan 17 13:00

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lunger John

Jan 17 13:00

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Norry Elliot

Jan 17 13:00